Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Non Lymphoblastic Leukemia
>>
Biogen
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Rituxan
(rituximab) / Roche
Intron A
(interferon α-2b) / Merck (MSD), Biogen
Zinbryta
(daclizumab) / Biogen, AbbVie
